Applied behavior analysis (ABA) is the gold‑standard autism therapy — but it has critics. Some autistic adults say ABA tries to “normalize” them, suppressing stimming and forcing eye contact at the cost of their mental health. The autism spectrum disorder market research shows that therapy accounts for 61% of treatment spending, with ABA being the largest slice. But modern ABA is evolving: it’s less about compliance and more about skill‑building, with a focus on the child’s well‑being.

Newer approaches like Naturalistic Developmental Behavioral Interventions (NDBIs) blend ABA with play‑based learning. The autism spectrum disorder market trends indicate that parent‑mediated therapies (where coaches train parents to deliver interventions) are also on the rise, especially in underserved areas.

Medication is a smaller segment but growing fast, driven by drugs for irritability (risperidone, aripiprazole) and off‑label use for anxiety or ADHD symptoms. No cure, but symptom management matters.

The key takeaway: listen to autistic voices. Good therapy empowers, it doesn’t erase. And the market is slowly shifting toward neurodiversity‑affirming care.